RU2017102358A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2017102358A3 RU2017102358A3 RU2017102358A RU2017102358A RU2017102358A3 RU 2017102358 A3 RU2017102358 A3 RU 2017102358A3 RU 2017102358 A RU2017102358 A RU 2017102358A RU 2017102358 A RU2017102358 A RU 2017102358A RU 2017102358 A3 RU2017102358 A3 RU 2017102358A3
- Authority
- RU
- Russia
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161498522P | 2011-06-17 | 2011-06-17 | |
| US61/498,522 | 2011-06-17 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2014101244A Division RU2610091C2 (ru) | 2011-06-17 | 2012-06-15 | (2S,5R)-5-[(бензилокси)амино]пиперидин-2-карбоксамид |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2017102358A RU2017102358A (ru) | 2018-12-19 |
| RU2017102358A3 true RU2017102358A3 (ru) | 2020-02-18 |
| RU2769076C2 RU2769076C2 (ru) | 2022-03-28 |
Family
ID=46317443
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2017102358A RU2769076C2 (ru) | 2011-06-17 | 2012-06-15 | Способ получения гетероциклических соединений, включая транс-7-оксо-6-(сульфокси)-1,6-диазабицикло[3.2.1]октан-2-карбоксамид и его соли |
| RU2014101244A RU2610091C2 (ru) | 2011-06-17 | 2012-06-15 | (2S,5R)-5-[(бензилокси)амино]пиперидин-2-карбоксамид |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2014101244A RU2610091C2 (ru) | 2011-06-17 | 2012-06-15 | (2S,5R)-5-[(бензилокси)амино]пиперидин-2-карбоксамид |
Country Status (18)
| Country | Link |
|---|---|
| US (4) | US8829191B2 (ru) |
| EP (1) | EP2721005B1 (ru) |
| JP (2) | JP6023800B2 (ru) |
| KR (1) | KR102143660B1 (ru) |
| CN (2) | CN103649051B (ru) |
| AR (1) | AR086972A1 (ru) |
| AU (1) | AU2012270051B2 (ru) |
| BR (1) | BR112013032415B1 (ru) |
| CA (1) | CA2780403C (ru) |
| ES (1) | ES2560404T3 (ru) |
| HK (1) | HK1196615A1 (ru) |
| IL (1) | IL229815A (ru) |
| MX (1) | MX361020B (ru) |
| MY (1) | MY165730A (ru) |
| RU (2) | RU2769076C2 (ru) |
| SG (1) | SG195289A1 (ru) |
| TW (1) | TWI565706B (ru) |
| WO (1) | WO2012172368A1 (ru) |
Families Citing this family (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8772490B2 (en) | 2010-12-22 | 2014-07-08 | Meiji Seika Pharma Co., Ltd. | Optically active diazabicyclooctane derivatives and process for preparing the same |
| CN103459372A (zh) * | 2011-03-31 | 2013-12-18 | 株式会社钟化 | 环状胺化合物的制造方法 |
| TWI565706B (zh) * | 2011-06-17 | 2017-01-11 | 阿斯特捷利康公司 | 用於製備包括反－７－酮基－６－（磺酸氧基）－１，６－二氮雜雙環［３，２，１］辛烷－２－甲醯胺之雜環化合物及其鹽類之方法 |
| US8796257B2 (en) | 2011-12-02 | 2014-08-05 | Naeja Pharmaceutical Inc. | Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors |
| US9505761B2 (en) | 2011-12-02 | 2016-11-29 | Fedora Pharmaceuticals Inc. | Bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors |
| CN104334558A (zh) | 2012-03-30 | 2015-02-04 | 丘比斯特药物股份有限公司 | 1,3,4-噁二唑和1,3,4-噻二唑β-内酰胺酶抑制剂 |
| US8916709B2 (en) | 2012-03-30 | 2014-12-23 | Cubist Pharmaceuticals, Inc. | 1,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitors |
| US8969570B2 (en) * | 2012-03-30 | 2015-03-03 | Cubist Pharmaceuticals, Inc. | Beta-lactamase inhibitors |
| SG11201406120SA (en) | 2012-03-30 | 2014-10-30 | Cubist Pharm Inc | ISOXAZOLE β-LACTAMASE INHIBITORS |
| CA2874279C (en) | 2012-05-30 | 2021-03-16 | Meiji Seika Pharma Co., Ltd. | Diazabicyclooctane derivatives useful as .beta.-lactamase inhibitor and process for preparing the same |
| WO2014069351A1 (ja) * | 2012-11-01 | 2014-05-08 | 株式会社カネカ | 光学活性二環式ウレア化合物の製造方法 |
| UA111925C2 (uk) * | 2012-12-11 | 2016-06-24 | Федора Фармасьютікалз Інк. | БІЦИКЛІЧНІ СПОЛУКИ ТА ЇХ ВИКОРИСТАННЯ ЯК АНТИБАКТЕРІАЛЬНИХ АГЕНТІВ ТА ІНГІБІТОРІВ β-ЛАКТАМАЗИ |
| NZ711343A (en) * | 2013-03-08 | 2016-07-29 | Wockhardt Ltd | Sodium salt of (2s, 5r)-6-benzyloxy-7-oxo-1,6-diaza-bicyclo [3.2.1 ] octane-2-carboxylic acid and its preparation |
| US9567335B2 (en) * | 2013-03-08 | 2017-02-14 | Wockhardt Limited | Process for sodium salt of (2S, 5R)-2-carboxamido-7-oxo-6-sulfooxy -1,6-diaza-bicyclo[3.2.1]octane |
| US9120795B2 (en) | 2013-03-14 | 2015-09-01 | Cubist Pharmaceuticals, Inc. | Crystalline form of a β-lactamase inhibitor |
| SG11201602256UA (en) * | 2013-09-24 | 2016-04-28 | Meiji Seika Pharma Co Ltd | Production method for diazabicyclooctane derivative and intermediary body thereof |
| US9120796B2 (en) | 2013-10-02 | 2015-09-01 | Cubist Pharmaceuticals, Inc. | B-lactamase inhibitor picoline salt |
| SG11201602723RA (en) * | 2013-10-08 | 2016-05-30 | Meiji Seika Pharma Co Ltd | Crystals of diazabicyclooctane derivative and production method for crystals of diazabicyclooctane derivative |
| US9657022B2 (en) * | 2014-01-21 | 2017-05-23 | Wockhardt Limited | 7-OXO-1,6-diazabicyclo[3.2.1]octane derivatives and their use as antibacterial agents |
| WO2015136473A1 (en) * | 2014-03-14 | 2015-09-17 | Wockhardt Limited | A process for preparation of sodium (2s, 5r)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylate |
| US10053460B2 (en) | 2014-12-02 | 2018-08-21 | Merck Sharp & Dohme Corp. | Process for the preparation of tert-butyl 4-((2S ,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamido)piperidine-1-carboxylate and analogs thereof |
| TWI691499B (zh) | 2014-12-05 | 2020-04-21 | 日商明治製菓藥業股份有限公司 | 二氮雜雙環辛烷衍生物之結晶及安定的凍結乾燥製劑的製造法 |
| PT3334734T (pt) | 2015-08-10 | 2020-04-06 | Sandoz Ag | Forma c de avibactam sódico |
| CN106749242B (zh) * | 2015-11-23 | 2021-04-02 | 上海医药工业研究院 | 阿维巴坦中间体的制备方法 |
| CN105348173B (zh) * | 2015-12-02 | 2017-12-15 | 中山奕安泰医药科技有限公司 | 不对称催化氢化法合成阿维巴坦中间体5的方法 |
| EP3411359B1 (en) * | 2016-02-04 | 2021-10-13 | Merck Sharp & Dohme Corp. | Methods of preparing hydroxylamine derivatives useful in the preparation of anti-infective agents |
| GB201602145D0 (en) * | 2016-02-05 | 2016-03-23 | Achieve Pharma Uk Ltd | Salt |
| CN105753867B (zh) * | 2016-03-24 | 2018-03-27 | 齐鲁制药有限公司 | 一种改进的阿维巴坦钠中间体化合物的制备方法 |
| CN107325096B (zh) * | 2016-04-29 | 2020-11-03 | 正大天晴药业集团股份有限公司 | 一种阿维巴坦单钠盐的结晶 |
| SG11201810725WA (en) | 2016-06-03 | 2018-12-28 | Medshine Discovery Inc | Novel β-lactamase inhibitors |
| CN107540601B (zh) * | 2016-06-28 | 2019-07-19 | 新发药业有限公司 | 5r-苄氧氨基哌啶-2s-甲酸酯及其草酸盐的便捷制备方法 |
| CN107540600B (zh) * | 2016-06-28 | 2019-07-09 | 新发药业有限公司 | 一种阿维巴坦中间体生产废液的回收利用方法 |
| US11124513B2 (en) | 2016-08-26 | 2021-09-21 | Sandoz Ag | Avibactam free acid |
| CN106432060A (zh) * | 2016-09-27 | 2017-02-22 | 海口南陆医药科技股份有限公司 | 一种阿维巴坦钠关键中间体的手性异构体的制备方法 |
| CN106565712A (zh) * | 2016-09-30 | 2017-04-19 | 天津津泰生物医药技术有限公司 | 一种阿维巴坦钠中间体的制备方法 |
| CN107880042A (zh) * | 2016-09-30 | 2018-04-06 | 上海复星星泰医药科技有限公司 | 阿维巴坦钠及其中间体化合物的制备方法 |
| CN108239089B (zh) * | 2016-12-27 | 2020-05-22 | 浙江医药股份有限公司新昌制药厂 | 一种阿维巴坦钠的合成方法 |
| CN108264480B (zh) * | 2016-12-30 | 2020-12-11 | 上海星泰医药科技有限公司 | 阿维巴坦钠中间体的制备方法 |
| CN106699756B (zh) * | 2016-12-30 | 2019-10-29 | 淄博鑫泉医药技术服务有限公司 | β内酰胺酶抑制剂阿维巴坦的合成方法 |
| US10434089B2 (en) | 2017-01-25 | 2019-10-08 | The Johns Hopkins University | Avibactam and carbapenems antibacterial agents |
| AU2018219569B2 (en) * | 2017-02-08 | 2021-11-11 | Sandoz Ag | Process for the preparation of crystalline form C of avibactam sodium |
| CN106831772B (zh) * | 2017-03-04 | 2019-12-17 | 丽珠医药集团股份有限公司 | 一种阿维巴坦中间体的合成方法 |
| KR20200030584A (ko) | 2017-07-21 | 2020-03-20 | 앤타바이오 에스에이에스 | 화합물 |
| CN109400521B (zh) * | 2017-08-18 | 2020-05-08 | 新发药业有限公司 | 一种改进的5r-苄氧氨基哌啶-2s-甲酸酯、其草酸盐的制备方法 |
| CN107417686B (zh) * | 2017-09-19 | 2020-04-28 | 北京化工大学 | 一种阿维巴坦钠的合成方法 |
| CN109678855B (zh) * | 2017-10-18 | 2020-07-17 | 新发药业有限公司 | 一种阿维巴坦中间体的制备方法 |
| CN109678856B (zh) * | 2017-10-18 | 2020-09-25 | 新发药业有限公司 | 一种阿维巴坦中间体的制备方法 |
| CN107941969B (zh) * | 2017-11-07 | 2021-03-02 | 中山奕安泰医药科技有限公司 | (2s,5r)-苯氧胺基哌啶-2-甲酰胺的检测方法 |
| CN107941944B (zh) * | 2017-11-23 | 2020-09-15 | 中山奕安泰医药科技有限公司 | 一种(2s,5r)-苄氧胺基哌啶-2-甲酸乙酯草酸盐的检测方法 |
| EP3719020B1 (en) | 2017-12-01 | 2022-09-21 | Qilu Pharmaceutical Co., Ltd. | Crystal form of beta-lactamase inhibitor and preparation method therefor |
| CN109912499B (zh) * | 2017-12-12 | 2021-04-27 | 江苏奥赛康药业有限公司 | 阿维巴坦中间体及其制备方法 |
| CN109928970B (zh) * | 2017-12-19 | 2020-04-28 | 新发药业有限公司 | 一种瑞利巴坦中间体的简便制备方法 |
| CN109956941B (zh) * | 2017-12-25 | 2020-08-04 | 新发药业有限公司 | 一种阿维巴坦的简便制备方法 |
| CN109970625B (zh) | 2017-12-28 | 2021-02-26 | 新发药业有限公司 | 一种5r-苄氧氨基哌啶-2s-甲酸或其衍生物的制备方法 |
| CN108373442B (zh) * | 2018-03-29 | 2020-07-03 | 台州职业技术学院 | 一种阿维巴坦中间异构体的回收方法 |
| CN108409736B (zh) * | 2018-05-16 | 2019-11-08 | 齐鲁天和惠世制药有限公司 | 一种喷雾干燥制备无定型阿维巴坦钠的方法 |
| EP3572411A1 (en) | 2018-05-21 | 2019-11-27 | Antabio SAS | Thiazole derivatives as metallo-beta-lactamase inhibitors |
| US11905286B2 (en) | 2018-08-09 | 2024-02-20 | Antabio Sas | Diazabicyclooctanones as inhibitors of serine beta-lactamases |
| EP3854786A4 (en) * | 2018-09-21 | 2022-09-14 | API Corporation | PROCESS FOR THE PREPARATION OF AMINO ACID DERIVATIVES |
| CN111072660B (zh) * | 2018-10-22 | 2021-05-18 | 新发药业有限公司 | 一种瑞来巴坦的简便制备方法 |
| CN109516987B (zh) * | 2018-12-26 | 2020-07-24 | 江西富祥药业股份有限公司 | 一种阿维巴坦中间体制备方法 |
| CN110437137A (zh) * | 2019-03-27 | 2019-11-12 | 成都克莱蒙医药科技有限公司 | 一种阿维巴坦中间体化合物的合成方法 |
| CN110577490B (zh) * | 2019-08-28 | 2020-09-22 | 山东安信制药有限公司 | 阿维巴坦中间体(2s,5s)-n-保护基-5-羟基-2-甲酸哌啶的合成方法 |
| CN110498762B (zh) * | 2019-08-28 | 2020-10-27 | 山东安信制药有限公司 | 一种(2s,5r)-5-[(苄氧基)氨基]-哌啶-2-甲酸乙酯的合成方法 |
| CN111116587A (zh) * | 2019-11-29 | 2020-05-08 | 北京耀诚惠仁科技有限公司 | 一种阿维巴坦中间体化合物的制备方法 |
| CN111777607A (zh) * | 2020-07-21 | 2020-10-16 | 海南海灵化学制药有限公司 | 一种阿维巴坦纳的制备方法 |
| CN115504913A (zh) * | 2021-06-23 | 2022-12-23 | 上海雨程生物科技有限公司 | 一种阿维巴坦钠中间体的合成方法 |
| CN115073458A (zh) * | 2022-07-04 | 2022-09-20 | 山东致泰医药技术有限公司 | 一种阿维巴坦钠的制备方法 |
| CN117486881A (zh) * | 2023-12-28 | 2024-02-02 | 成都克莱蒙医药科技有限公司 | 一种阿维巴坦中间体的制备方法 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69535592T2 (de) | 1994-03-25 | 2008-06-12 | Isotechnika, Inc., Edmonton | Verbesserung der effektivität von arzneimitteln duren deuterierung |
| US6334997B1 (en) | 1994-03-25 | 2002-01-01 | Isotechnika, Inc. | Method of using deuterated calcium channel blockers |
| TW473479B (en) | 1997-12-19 | 2002-01-21 | Takeda Chemical Industries Ltd | Phosphonocephem derivatives, their production and use |
| FR2812635B1 (fr) * | 2000-08-01 | 2002-10-11 | Aventis Pharma Sa | Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens |
| EP1310502B1 (en) | 2000-08-10 | 2009-05-20 | Takeda Pharmaceutical Company Limited | Phosphonocephem compound |
| FR2835186B1 (fr) * | 2002-01-28 | 2006-10-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases |
| JP4956191B2 (ja) * | 2003-10-17 | 2012-06-20 | インサイト コーポレーション | マトリックスメタロプロテイナーゼの阻害剤としての置換環状ヒドロキサメート |
| CA2580621A1 (en) * | 2004-09-24 | 2006-03-30 | Actelion Pharmaceuticals Ltd | New bicyclic antibiotics |
| MX2007014507A (es) * | 2005-05-24 | 2008-02-07 | Astrazeneca Ab | Aminopiperidin quinolinas y sus analogos azaisostericos con actividad antibacteriana. |
| WO2008042227A1 (en) | 2006-09-28 | 2008-04-10 | Med Institute, Inc. | Medical device including an anesthetic and method of preparation thereof |
| FR2921060B1 (fr) | 2007-09-14 | 2012-06-15 | Novexel | Nouveau procede de preparation d'une piperidine disubsituee et nouveaux intermediaires |
| DK2231667T3 (da) * | 2008-01-18 | 2013-12-16 | Merck Sharp & Dohme | Beta-lactamase-hæmmere |
| WO2010126820A2 (en) * | 2009-04-30 | 2010-11-04 | Merck Sharp & Dohme Corp. | Preparation of alkyl esters of n-protected oxo-azacycloalkylcarboxylic acids |
| BR112012006250B1 (pt) | 2009-09-21 | 2021-07-06 | Pfizer Anti-Infectives Ab | composições para tratar infecções bacterianas usando ceftaroline |
| FR2951171A1 (fr) * | 2009-10-09 | 2011-04-15 | Novexel | Nouveau sel de sodium d'un compose azabicyclique sous forme enantiomere cristallisee et nouvelles formes polymorphes et pseudopolymorphes ainsi que leur preparation |
| US8999957B2 (en) * | 2010-06-24 | 2015-04-07 | Merck Sharp & Dohme Corp. | Heterocyclic compounds as ERK inhibitors |
| HUE032491T2 (en) * | 2010-12-22 | 2017-09-28 | Meiji Seika Pharma Co Ltd | An optically active diaza-bicyclooctane derivative and a process for its preparation |
| CN103459372A (zh) * | 2011-03-31 | 2013-12-18 | 株式会社钟化 | 环状胺化合物的制造方法 |
| TWI565706B (zh) * | 2011-06-17 | 2017-01-11 | 阿斯特捷利康公司 | 用於製備包括反－７－酮基－６－（磺酸氧基）－１，６－二氮雜雙環［３，２，１］辛烷－２－甲醯胺之雜環化合物及其鹽類之方法 |
| US10158850B2 (en) * | 2011-08-25 | 2018-12-18 | Telefonaktiebolaget Lm Ericsson (Publ) | Depth map encoding and decoding |
| ES2606059T3 (es) * | 2011-08-30 | 2017-03-17 | Wockhardt Limited | Derivados de 1,6-diazabiciclo[3,2,1]octan-7-ona y su uso en el tratamiento de infecciones bacterianas |
-
2012
- 2012-06-15 TW TW101121652A patent/TWI565706B/zh active
- 2012-06-15 KR KR1020137033079A patent/KR102143660B1/ko active IP Right Grant
- 2012-06-15 MY MYPI2013702441A patent/MY165730A/en unknown
- 2012-06-15 BR BR112013032415-5A patent/BR112013032415B1/pt active IP Right Grant
- 2012-06-15 CN CN201280029765.7A patent/CN103649051B/zh active Active
- 2012-06-15 CA CA2780403A patent/CA2780403C/en active Active
- 2012-06-15 US US13/524,007 patent/US8829191B2/en active Active
- 2012-06-15 JP JP2014515292A patent/JP6023800B2/ja active Active
- 2012-06-15 EP EP12727922.2A patent/EP2721005B1/en active Active
- 2012-06-15 MX MX2013014114A patent/MX361020B/es active IP Right Grant
- 2012-06-15 RU RU2017102358A patent/RU2769076C2/ru active
- 2012-06-15 SG SG2013089578A patent/SG195289A1/en unknown
- 2012-06-15 WO PCT/GB2012/051388 patent/WO2012172368A1/en active Application Filing
- 2012-06-15 ES ES12727922.2T patent/ES2560404T3/es active Active
- 2012-06-15 AU AU2012270051A patent/AU2012270051B2/en active Active
- 2012-06-15 CN CN201510720279.5A patent/CN105294690B/zh active Active
- 2012-06-15 RU RU2014101244A patent/RU2610091C2/ru active
- 2012-06-18 AR ARP120102159 patent/AR086972A1/es active IP Right Grant
-
2013
- 2013-12-05 IL IL229815A patent/IL229815A/en active IP Right Grant
-
2014
- 2014-02-14 US US14/180,656 patent/US8969566B2/en active Active
- 2014-10-10 HK HK14110118.0A patent/HK1196615A1/zh unknown
-
2015
- 2015-01-05 US US14/589,194 patent/US9284314B2/en active Active
-
2016
- 2016-02-10 US US15/040,654 patent/US9695122B2/en active Active
- 2016-10-07 JP JP2016199214A patent/JP6342462B2/ja active Active